1. Home
  2. CDP vs CDTX Comparison

CDP vs CDTX Comparison

Compare CDP & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo COPT Defense Properties of Beneficial Interest

CDP

COPT Defense Properties of Beneficial Interest

HOLD

Current Price

$29.49

Market Cap

3.3B

Sector

Real Estate

ML Signal

HOLD

Logo Cidara Therapeutics Inc.

CDTX

Cidara Therapeutics Inc.

HOLD

Current Price

$220.50

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDP
CDTX
Founded
1988
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CDP
CDTX
Price
$29.49
$220.50
Analyst Decision
Buy
Buy
Analyst Count
7
12
Target Price
$33.29
$128.75
AVG Volume (30 Days)
934.6K
2.3M
Earning Date
10-30-2025
11-06-2025
Dividend Yield
4.18%
N/A
EPS Growth
9.45
N/A
EPS
1.32
N/A
Revenue
$752,757,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.48
N/A
P/E Ratio
$22.09
N/A
Revenue Growth
0.43
N/A
52 Week Low
$23.92
$15.22
52 Week High
$32.94
$221.20

Technical Indicators

Market Signals
Indicator
CDP
CDTX
Relative Strength Index (RSI) 51.92 86.62
Support Level $28.57 $219.60
Resistance Level $29.57 $220.38
Average True Range (ATR) 0.56 0.74
MACD -0.14 -3.92
Stochastic Oscillator 39.36 67.82

Price Performance

Historical Comparison
CDP
CDTX

About CDP COPT Defense Properties of Beneficial Interest

COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. Its tenants include the USG and their defense contractors, who are engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. Its properties include 195 operating properties totaling approximately 22.4 million square feet comprised of 16.5 million square feet in 164 office properties and 5.9 million square feet in 31 single-tenant data center shells.

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Share on Social Networks: